SCHEMBL2814833

SCHEMBL2814833

CCN1C(=O)COc2ccc(C(O)(C(C)c3ccc(-c4ccc(C(=O)OC)c(Cl)c4)cc3Cl)C(F)(F)F)cc21

nearest known ligand 0.42

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
USP2 O75604 1/20 0.39
HTT P42858 1/20 0.39
ALDH1A1 P00352 2/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
TSHR P16473 1/20 0.37
NPSR1 Q6W5P4 1/20 0.37
SLC5A1 P13866 3/20 0.37
SLC5A2 P31639 3/20 0.37
BRD4 O60885 1/20 0.37
KDM4E B2RXH2 2/20 0.37
POLB P06746 1/20 0.36
THRB P10828 1/20 0.36
RORC P51449 1/20 0.36
KMT2A Q03164 2/20 0.35
MEN1 O00255 1/20 0.35
PDK2 Q15119 1/20 0.35
ALOX15 P16050 1/20 0.34
KMO O15229 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2817146 0.95 USP2 (0.38) USP2HTTALDH1A1L3MBTL1TSHR
SCHEMBL2817251 0.95 USP2 (0.39) USP2HTTALDH1A1L3MBTL1TSHR
SCHEMBL474526 0.92 USP2 (0.42) USP2HTTALDH1A1L3MBTL1TSHR
SCHEMBL474545 0.91 ALDH1A1 (0.42) USP2HTTALDH1A1L3MBTL1TSHR
SCHEMBL12163919 0.91 ALDH1A1 (0.42) USP2HTTALDH1A1L3MBTL1TSHR
SCHEMBL474578 0.91 TSHR (0.36) USP2HTTALDH1A1L3MBTL1TSHR
SCHEMBL2815546 0.91 USP2 (0.42) USP2HTTALDH1A1L3MBTL1TSHR
SCHEMBL12163824 0.90 GPR55 (0.39) USP2HTTALDH1A1L3MBTL1TSHR
SCHEMBL474432 0.90 GPR55 (0.39) USP2HTTALDH1A1L3MBTL1TSHR
SCHEMBL12163929 0.88 ALDH1A1 (0.41) USP2HTTALDH1A1L3MBTL1TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2411365-B1 2,3-DIARYL- OR HETEROARYL-SUBSTITUTED 1,1,1-TRIFLUORO-2-HYDROXYPROPYL COMPOUNDS HOFFMANN LA ROCHE (CH) 2014-03-19 EP disclosed
US-20130172335-A1 2,3-DIARYL- OR HETEROARYL-SUBSTITUTED 1,1,1-TRIFLUORO-2-HYDROXYPROPYL COMPOUNDS HOFFMANN-LA ROCHE INC. (US) 2013-07-04 US disclosed
US-8450313-B2 2,3-diaryl- or heteroaryl-substituted 1,1,1-trifluoro-2-hydroxypropyl compounds HOFFMANN-LA ROCHE INC. (US) 2013-05-28 US disclosed
US-8268820-B2 2,3-diaryl- or heteroaryl-substituted 1,1,1-trifluoro-2-hydroxypropyl compounds HOFFMANN-LA ROCHE INC. (US) 2012-09-18 US disclosed
US-20120232071-A1 2,3-DIARYL- OR HETEROARYL-SUBSTITUTED 1,1,1-TRIFLUORO-2-HYDROXYPROPYL COMPOUNDS HUNZIKER DANIEL (CH) 2012-09-13 US disclosed
US-20100249124-A1 2,3-DIARYL- OR HETEROARYL-SUBSTITUTED 1,1,1-TRIFLUORO-2-HYDROXYPROPYL COMPOUNDS HOFFMANN-LA ROCHE, INC. 2010-09-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130172335-A1 2,3-DIARYL- OR HETEROARYL-SUBSTITUTED 1,1,1-TRIFLUORO-2-HYDROXYPROPYL COMPOUNDS NR3C1, NR3C2, MC2R USP2 4222/4885HTT 1633/4885ALDH1A1 708/4885
US-20100249124-A1 2,3-DIARYL- OR HETEROARYL-SUBSTITUTED 1,1,1-TRIFLUORO-2-HYDROXYPROPYL COMPOUNDS NR3C1, NR3C2, MC2R USP2 4305/4885HTT 1502/4885ALDH1A1 725/4885
US-20120232071-A1 2,3-DIARYL- OR HETEROARYL-SUBSTITUTED 1,1,1-TRIFLUORO-2-HYDROXYPROPYL COMPOUNDS NR3C1, NR3C2, MC2R USP2 4222/4885HTT 1633/4885ALDH1A1 708/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.